Revolution Medicines, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Revolution Medicines has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation advisory votes.
NASDAQ
Revolution Medicines has scheduled its 2025 Annual Meeting for June 26, 2025, where stockholders will vote on the election of directors, ratification of the company's accounting firm, and executive compensation.
NASDAQ
Revolution Medicines will hold its 2025 Annual Meeting of Stockholders online on June 26, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
DEFA14A: Revolution Medicines Sets Date for 2024 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Revolution Medicines has scheduled its 2024 Annual Meeting for June 20, 2024, and is urging stockholders to vote on key proposals, including the election of directors and ratification of the company's accounting firm.
NASDAQ
Revolution Medicines will hold its 2024 Annual Meeting of Stockholders online on June 20, 2024, to vote on director elections, auditor ratification, and executive compensation.